Regulatory status (as of publication): Not approved by the FDA, EMA, or any other regulatory authority for any indication
Medical Disclaimer The information on this page is intended for educational and informational purposes only and should not be considered medical advice, diagnosis, or treatment
Compared to thermogenics and stimulants Traditional thermogenic compounds like caffeine, synephrine, or more potent stimulants increase metabolic rate through sympathetic nervous system activation
Some patients may require more frequent administration, but this should only be adjusted under clinical supervision after excluding other causes of persistent symptoms
While the RNI for maintenance is only 1.5 g daily, therapeutic oral doses typically range from: 50-150 g daily for mild deficiency prevention in at-risk groups 1,000-2,000 g daily for treating confirmed deficiency without malabsorption Some formulations contain up to 5,000 g, though there is no proven additional benefit over 1,000-2,000 g for most patients The reason for this dosage discrepancy lies in absorption efficiency
Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials